The Immune System – News and Features

Many disease-causing bacteria are encased in a sugar layer called the capsular polysaccharide (CPS). Features of the CPS that help the bacteria to colonise the human respiratory tract were identified in a ground-breaking study.

If approved, drug could change standard care.

New work from researchers at the UC Davis School of Veterinary Medicine shows how memory T cells, crucial for a vaccine that induces a powerful immune response, can be recruited into the liver in a mouse model ofSalmonella.

A new study has suggested that a drug formulation derived from indirubin, a molecule found in indigo plants used in Chinese medicine, can improve glioblastoma survival in mice.

New research has provided more insight into why some lung cancers respond to immunotherapy while others don't.

Scientists are warning that Crimean-Congo hemorrhagic fever, which can kill between 10% and 40% of patients, is spreading northward and westward in Europe.

Researchers have developed a 3D bioprinting ink that induces tissue regeneration without photocuring. With expected applications including patient-specific regenerative treatment technologies, such as artificial organs.

A new clinical trial – the results of which are due to be presented at the annual meeting of the American Association for Cancer Research – has shown that adding an mRNA vaccine to immunotherapy for melanoma boosts effectiveness.

A new clinical trial will investigate the safety and efficacy of a vaccine for the prevention of Lyme disease in children over the age of five.

A new artificial intelligence model could bring clarity to doctors delivering prognoses and deciding on treatments for patients with colorectal cancer